Related Experiment Video
Updated: Mar 17, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Are Adiponectin and Insulin Resistance Related to Stress Hyperglycaemia in Critically Ill Patients?
Perihan Ülger1,2, Ebru Yildiz1,2, Andreas Kribben1,2
1Department of Nephrology, University Duisburg-Essen, Essen, 2 Endokrinologikum, and Asklepios Medical SchDepartment of Medicine, Rotes Kreuz Krankenhaus Bremen, Bremen, Germany.
Abstract:
Stress hyperglycaemia (SH) is frequent in critical illness, increases morbidity and mortality and is strongly associated with acute kidney injury (AKI). It remains unanswered whether insulin resistance or decreased adiponectin contribute to SH as they do to chronic hyperglycaemia. Our aims were to identify potential relationships between insulin resistance, serum high molecular weight (HMW) adiponectin and SH, while controlling for and excluding other risk factors and confounders of both SH and chronic hyperglycaemia such as diabetes, as well as potential relationships between HMW-adiponectin and subsequent AKI. We studied 158 critically ill patients admitted to intensive care units. SH was defined by blood glucose > 140 mg/dl, insulin resistance as Homeostasis model assessment-2-scores above the 75th percentile, decreased HMW-adiponectin as values below the 25th percentile, and AKI by Kidney-Disease-Improving-Global-Outcomes criteria. Seventy-seven patients (48.7%) featured SH. Patients with and without SH were well balanced in regard to most factors causing chronic hyperglycaemia. The SH group had substantially higher HOMA-2-scores and lower serum HMW-adiponectin levels. Adjusted to risk factors of SH and chronic hyperglycaemia, both insulin resistance and decreased serum HMW-adiponectin levels were independently and strongly related to SH (adjusted odds ratios 7.24 (95% confidence interval 3.17-19.01) and 3.10 (95% confidence interval 1.61-5.47), respectively). In the subgroups of SH and non-SH patients without AKI, HMW-adiponectin was significantly higher. In conclusion, insulin resistance and decreased HMW-adiponectin may be risk factors of SH in critically ill patients. In addition, elevated serum HMW-adiponectin may attenuate AKI irrespective of SH.
Supplementary Information:
The online version contains supplementary material available at 10.1007/s12291-024-01232-w.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hypothalamic-Pituitary Axis
Acute Pancreatitis II: Clinical Manifestations and Management